Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129 | -85 | -27 | -141 | -95 |
| Accounts payable and accrued liabilities | -24 | N/A | N/A | N/A | N/A |
| Other Working Capital | -24 | -25 | -40 | 0 | -22 |
| Other Operating Activity | 24 | 0 | 0 | 4 | 4 |
| Operating Cash Flow | $-153 | $-110 | $-66 | $-137 | $-113 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 552 | 552 | N/A | -552 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 61 | 61 |
| Investing Cash Flow | $552 | $552 | $N/A | $-492 | $61 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 180 | 180 | 180 | 808 | 808 |
| End Cash Position | 579 | 622 | 113 | 180 | 756 |
| Net Cash Flow | $400 | $443 | $-66 | $-628 | $-52 |
| Free Cash Flow | |||||
| Operating Cash Flow | -153 | -110 | -66 | -137 | -113 |
| Free Cash Flow | -153 | -110 | -66 | -137 | -113 |